430 related articles for article (PubMed ID: 10803465)
41. SH2-B and APS are multimeric adapters that augment TrkA signaling.
Qian X; Ginty DD
Mol Cell Biol; 2001 Mar; 21(5):1613-20. PubMed ID: 11238898
[TBL] [Abstract][Full Text] [Related]
42. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.
Eggert A; Sieverts H; Ikegaki N; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):573-6. PubMed ID: 11107120
[TBL] [Abstract][Full Text] [Related]
43. The effect of P75 on Trk receptors in neuroblastomas.
Ho R; Minturn JE; Simpson AM; Iyer R; Light JE; Evans AE; Brodeur GM
Cancer Lett; 2011 Jun; 305(1):76-85. PubMed ID: 21419569
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
45. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
46. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1.
Harada T; Morooka T; Ogawa S; Nishida E
Nat Cell Biol; 2001 May; 3(5):453-9. PubMed ID: 11331872
[TBL] [Abstract][Full Text] [Related]
47. Chloride channel 4 is required for nerve growth factor-induced TrkA signaling and neurite outgrowth in PC12 cells and cortical neurons.
Hur J; Jeong HJ; Park J; Jeon S
Neuroscience; 2013 Dec; 253():389-97. PubMed ID: 24036377
[TBL] [Abstract][Full Text] [Related]
48. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
Wert MM; Palfrey HC
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
[TBL] [Abstract][Full Text] [Related]
49. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo.
Matsushima H; Bogenmann E
Mol Cell Biol; 1993 Dec; 13(12):7447-56. PubMed ID: 8246962
[TBL] [Abstract][Full Text] [Related]
50. GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways.
Lou X; Yano H; Lee F; Chao MV; Farquhar MG
Mol Biol Cell; 2001 Mar; 12(3):615-27. PubMed ID: 11251075
[TBL] [Abstract][Full Text] [Related]
51. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
52. Methylmercury inhibits TrkA signaling through the ERK1/2 cascade after NGF stimulation of PC12 cells.
Parran DK; Barone S; Mundy WR
Brain Res Dev Brain Res; 2004 Mar; 149(1):53-61. PubMed ID: 15013629
[TBL] [Abstract][Full Text] [Related]
53. PC12 cells have caveolae that contain TrkA. Caveolae-disrupting drugs inhibit nerve growth factor-induced, but not epidermal growth factor-induced, MAPK phosphorylation.
Peiró S; Comella JX; Enrich C; Martín-Zanca D; Rocamora N
J Biol Chem; 2000 Dec; 275(48):37846-52. PubMed ID: 10982788
[TBL] [Abstract][Full Text] [Related]
54. Nerve growth factor in combination with second messenger analogues causes neuronal differentiation of PC12 cells expressing a dominant inhibitory Ras protein without inducing activation of extracellular signal-regulated kinases.
Boglári G; Szeberényi J
Eur J Neurosci; 2001 Nov; 14(9):1445-54. PubMed ID: 11722606
[TBL] [Abstract][Full Text] [Related]
55. Effects of thimerosal on NGF signal transduction and cell death in neuroblastoma cells.
Parran DK; Barker A; Ehrich M
Toxicol Sci; 2005 Jul; 86(1):132-40. PubMed ID: 15843506
[TBL] [Abstract][Full Text] [Related]
56. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
57. Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells.
Olsson AK; Vadhammar K; Nånberg E
Exp Cell Res; 2000 May; 256(2):454-67. PubMed ID: 10772818
[TBL] [Abstract][Full Text] [Related]
58. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
59. Effect of cell differentiation for neuroblastoma by vitamin k analogs.
Nakayama T; Asami S; Ono S; Miura M; Hayasaka M; Yoshida Y; Toriyama M; Motohashi S; Suzuki T
Jpn J Clin Oncol; 2009 Apr; 39(4):251-9. PubMed ID: 19273458
[TBL] [Abstract][Full Text] [Related]
60. A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-gamma 1 abolishes NGF-promoted peripherin induction but not neurite outgrowth.
Loeb DM; Stephens RM; Copeland T; Kaplan DR; Greene LA
J Biol Chem; 1994 Mar; 269(12):8901-10. PubMed ID: 7510697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
